Global Boron Carbide Market was valued at US$ 314.11 million in 2023 and is projected to hit the market valuation of US$ 457.84 million by 2032 at a CAGR of 4.49% during the forecast period 2024–2032.

The facility, sometimes referred to as "artificial sun," is being built by China, the European Union, India, Japan, the Republic of Korea (ROK), Russia and the United States to test the feasibility of ...

The BrioVAD System is a full-support, durable ventricular assist device designed to enhance the quality of life in patients.

This multiyear follow-up of more than 3300 patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) who ...

How to build a beautiful wood stove from clay Building a beautiful wood stove from clay can be a rewarding and practical ...

Traditional market downstream testwork conducted at independent consultancy ProGraphite GmbH (ProGraphite) in Germany has ...

The novel therapy, delivered via implantable, pill-sized device, improved RA signs and symptoms in patients receiving daily ...

Patients with relapsed or refractory MDS may experience improved overall survival with , depending on certain prognostic ...

The U.S. patient population for Revuforj in its approved indication is roughly 2,000 according to Syndax. KMT2A leukemias ...

RHI Magnesita, the world's leading refractory producer, sees India as its only growth market. While the global market shrinks ...

Reprioritized resources to reduce costs and enhance focus on Nana-val's development program in relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL) - - On track to report data ...